This activity was originally presented at the 2026 Diabetes Day of Education.
Program Description
With over 38 million Americans now living with diabetes and continuous glucose monitoring (CGM) usage increasing more than twofold in the last decade, the management of diabetes as a chronic condition has rapidly shifted from reactive fingersticks to proactive, real-time data integration. Despite these technological strides, pharmacists and pharmacy technicians face significant challenges, including navigating complex administrative barriers to device access and ensuring that diverse patient populations can effectively utilize these tools to avoid diabetes-related complications. Pharmacists have become essential partners in diabetes care, facilitating the implementation of clinical guidelines and providing individualized care. This program will review the prevalence of diabetes before diving into modern glycemic management strategies featuring CGM devices, with attention on the different features of available prescription CGM devices in the community setting. In addition to highlights of the 2026 ADA Standards of Care, the session will review critical technological updates, such as the transition to updated CGM systems, the integration of CGM with automated insulin delivery (AID) systems, and the development of continuous ketone monitoring, while also providing practical updates on access and coverage considerations. By examining real-world use and strategies to overcome utilization barriers, this session will empower pharmacists and pharmacy technicians to improve their decision-making and better support people living with diabetes in achieving optimal metabolic health.
Target audience: Community pharmacists and pharmacy technicians
Type of activity: Application
Release date: May 22, 2026
Expiration date: May 22, 2027
Learner level: Intermediate, Foundational
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, pharmacists will be able to:
- Discover current recommendations for the treatment and management of diabetes
- Differentiate common diabetes-related complications and their impact on patient health and quality of life, emphasizing how technology can help reduce these risks
- Investigate strategies to overcome barriers to continuous glucose monitor access and use across diverse patient populations